Frontage Holdings Corp
HKEX:1521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Frontage Holdings Corp
HKEX:1521
|
US |
|
V
|
Venator Materials PLC
OTC:VNTRF
|
UK |
|
C
|
Cleveland-Cliffs Inc
SWB:CVA
|
US |
|
H
|
Huntington Bancshares Inc
DUS:HU3
|
US |
|
D
|
Dai Nippon Printing Co Ltd
F:DNP
|
JP |
|
N
|
Novo Nordisk A/S
XMUN:NOV
|
DK |
|
C
|
Com7 PCL
SET:COM7
|
TH |
|
J
|
JLS Co Ltd
KOSDAQ:040420
|
KR |
Intrinsic Value
Is Frontage Holdings Corp undervalued or overvalued?
See the intrinsic value estimate for Frontage Holdings Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Frontage Holdings Corp looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Frontage Holdings Corp’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Frontage Does
Frontage Holdings Corp is a contract research organization that helps pharmaceutical and biotech companies develop new drugs. It provides laboratory and research services such as drug discovery support, preclinical testing, bioanalysis, chemistry, and clinical trial-related lab work. In simple terms, it is a behind-the-scenes research partner that helps customers move medicines from the lab toward human testing and regulatory approval.
- Headquarters
- United States of America US
- Employees
- 1 523
- IPO date
- May 30, 2019
Earnings Waterfall
Frontage Holdings Corp
The intrinsic value for Frontage Holdings Corp (1521) under the Base Case is hidden HKD.
Compared with the current market price of 1.49 HKD, the stock appears hidden.